The effects of α-tocopherol on bone: A double-edged sword?

Nutrients

Volumn 6, Issue 4, 2014, Pages 1424-1441

  Chin, Kok Yong ^a   Ima Nirwana, Soelaiman ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Bone; Fracture; Osteoporosis; Vitamin E; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; CALCIUM; COLLAGEN TYPE 1; MALONALDEHYDE; MESSENGER RNA; OSTEOCALCIN; OSTEONECTIN; TRANSCRIPTION FACTOR RUNX; VITAMIN K GROUP;

AGE; BONE; BONE DENSITY; BONE MASS; CELL DIFFERENTIATION; CLINICAL TRIAL (TOPIC); DIETARY INTAKE; DOSE RESPONSE; DRUG EFFICACY; FRACTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; MICROARRAY ANALYSIS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; OVARIECTOMY; OXIDATIVE STRESS; POSTMENOPAUSE; PROTEIN EXPRESSION; PROTHROMBIN TIME; QUESTIONNAIRE; REVIEW; SMOKING; UNSPECIFIED SIDE EFFECT; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; DIET SUPPLEMENTATION; DRUG EFFECTS; METABOLISM; OBSERVATIONAL STUDY;

ALPHA-TOCOPHEROL; BONE AND BONES; BONE DENSITY; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OBSERVATIONAL STUDY AS TOPIC; OSTEOPOROSIS; VITAMIN E; VITAMIN K;

EID: 84898934852     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu6041424     Document Type: Review

References (79)

1. Kular, J.; Tickner, J.; Chim, S. M.; Xu, J. An overview of the regulation of bone remodelling at the cellular level. Clin. Biochem. 2012, 45, 863-873.
2. World Health Organization. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis: Report of a World Health Organization Study Group; World Health Organization: Geneva, Switzerland, 1994.
3. Chin, K. Y.; Ima-Nirwana, S. Sex steroids and bone health status in men. Int. J. Endocrinol. 2012, 2012, doi: 10. 1155/2012/208719.
4. Riggs, B. L.; Khosla, S.; Melton, L. J. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 2002, 23, 279-302.
5. Khosla, S. Pathogenesis of age-related bone loss in humans. J. Gerontol. 2013, 68, 1226-1235.
6. Lane, N. E. Epidemiology, etiology, and diagnosis of osteoporosis. Am. J. Obstet. Gynecol. 2006, 194, S3-S11.
7. National Osteoporosis Foundation. Physician's Guide to Prevention and Treatment of Osteoporosis; National Osteoporosis Foundation: Washington, DC, USA, 2003; pp. 1-20.
8. Ahn, S. H.; Lee, S. H.; Kim, B. J.; Lim, K. H.; Bae, S. J.; Kim, E. H.; Kim, H. K.; Choe, J. W.; Koh, J. M.; Kim, G. S. Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women. Osteoporos. Int. 2013, 24, 2961-2970.
9. Basu, S.; Michaëlsson, K.; Olofsson, H.; Johansson, S.; Melhus, H. Association between oxidative stress and bone mineral density. Biochem. Biophys. Res. Commun. 2001, 288, 275-279.
10. Kuyumcu, M. E.; Yesil, Y.; Oztürk, Z. A.; Ci{dotless}nar, E.; Ki{dotless}zi{dotless}larslanoglu, C.; Halil, M.; Ulger, Z.; Yesil, N. K.; Cankurtaran, M.; Ari{dotless}oǧul, S. The association between homocysteine (Hcy) and serum natural antioxidants in elderly bone mineral densitometry (BMD). Arch. Gerontol. Geriatr. 2012, 55, 739-743.
11. Sugiura, M.; Nakamura, M.; Ogawa, K.; Ikoma, Y.; Ando, F.; Yano, M. Bone mineral density in post-menopausal female subjects is associated with serum antioxidant carotenoids. Osteoporos. Int. 2008, 19, 211-219.
12. Altindag, O.; Erel, O.; Soran, N.; Celik, H.; Selek, S. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatol. Int. 2008, 28, 317-321.
13. Sanchez-Rodriguez, M.; Ruiz-Ramos, M.; Correa-Munoz, E.; Mendoza-Nunez, V. Oxidative stress as a risk factor for osteoporosis in elderly mexicans as characterized by antioxidant enzymes. BMC Musculoskelet. Disord. 2007, 8, doi: 10. 1186/1471-2474-8-124.
14. Hyeon, S.; Lee, H.; Yang, Y.; Jeong, W. Nrf2 deficiency induces oxidative stress and promotes rankl-induced osteoclast differentiation. Free Radic. Biol. Med. 2013, 65, 789-799.
15. Bai, X. C.; Lu, D.; Bai, J.; Zheng, H.; Ke, Z. Y.; Li, X. M.; Luo, S. Q. Oxidative stress inhibits osteoblastic differentiation of bone cells by erk and NF-κB. Biochem. Biophys. Res. Commun. 2004, 314, 197-207.
16. Wauquier, F.; Leotoing, L.; Coxam, V.; Guicheux, J.; Wittrant, Y. Oxidative stress in bone remodelling and disease. Trends Mol. Med. 2009, 15, 468-477.
17. Bai, X.-C.; Lu, D.; Liu, A.-L.; Zhang, Z.-M.; Li, X.-M.; Zou, Z.-P.; Zeng, W.-S.; Cheng, B.-L.; Luo, S.-Q. Reactive oxygen species stimulates receptor activator of NF-κB ligand expression in osteoblast. J. Biol. Chem. 2005, 280, 17497-17506.
18. Chaturvedi, R.; Singha, P. K.; Dey, S. Water soluble bioactives of nacre mediate antioxidant activity and osteoblast differentiation. PLoS One 2013, 8, e84584.
19. Zeng, X.; Tian, J.; Cai, K.; Wu, X.; Wang, Y.; Zheng, Y.; Su, Y.; Cui, L. Promoting osteoblast differentiation by the flavanes from huangshan maofeng tea is linked to a reduction of oxidative stress. Phytomedicine 2014, 21, 217-224.
20. Nizar, A. M.; Nazrun, A. S.; Norazlina, M.; Norliza, M.; Ima Nirwana, S. Low dose of tocotrienols protects osteoblasts against oxidative stress. Clin. Ther. 2011, 162, 533-538.
21. Singh, T.; Newman, A. B. Inflammatory markers in population studies of aging. Ageing Res. Rev. 2011, 10, 319-329.
22. Khosla, S.; Atkinson, E. J.; Dunstan, C. R.; O'Fallon, W. M. Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J. Clin. Endocrinol. Metab. 2002, 87, 1550-1554.
23. Pfeilschifter, J.; Köditz, R.; Pfohl, M.; Schatz, H. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 2002, 23, 90-119.
24. Schett, G. Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur. J. Clin. Investig. 2011, 41, 1361-1366.
25. Weitzmann, M. N. The role of inflammatory cytokines, the RANKL/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis. Scientifica 2013, 2013, doi: 10. 1155/2013/125705.
26. Spilmont, M.; Léotoing, L.; Davicco, M.-J.; Lebecque, P.; Mercier, S.; Miot-Noirault, E.; Pilet, P.; Rios, L.; Wittrant, Y.; Coxam, V. Pomegranate and its derivatives can improve bone health through decreased inflammation and oxidative stress in an animal model of postmenopausal osteoporosis. Eur. J. Nutr. 2013, doi: 10. 1007/s00394-013-0615-6.
27. Shen, C.-L.; Yeh, J. K.; Cao, J. J.; Tatum, O. L.; Dagda, R. Y.; Wang, J.-S. Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model. J. Nutr. Biochem. 2010, 21, 968-974.
28. Nazrun, A. S.; Norazlina, M.; Norliza, M.; Nirwana, S. I. The anti-inflammatory role of vitamin E in prevention of osteoporosis. Adv. Pharmacol. Sci. 2012, 2012, doi: 10. 1155/2012/142702.
29. Macdonald, H. M.; New, S. A.; Golden, M. H.; Campbell, M. K.; Reid, D. M. Nutritional associations with bone loss during the menopausal transition: Evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am. J. Clin. Nutr. 2004, 79, 155-165.
30. Wolf, R. L.; Cauley, J. A.; Pettinger, M.; Jackson, R.; Lacroix, A.; Leboff, M. S.; Lewis, C. E.; Nevitt, M. C.; Simon, J. A.; Stone, K. L.; et al. Lack of a relation between vitamin and mineral antioxidants and bone mineral density: Results from the women's health initiative. Am. J. Clin. Nutr. 2005, 82, 581-588.
31. Mata-Granados, J. M.; Cuenca-Acebedo, R.; Luque de Castro, M. D.; Quesada Gomez, J. M. Lower vitamin E serum levels are associated with osteoporosis in early postmenopausal women: A cross-sectional study. J. Bone Miner. Metab. 2013, 31, 455-460.
32. Aggarwal, B.; Sundaram, C.; Prasad, S.; Kannappan, R. Tocotrienols, the vitamin E of the 21st century: It's potential against cancer and other chronic diseases. Biochem. Pharmacol. 2010, 80, 1613-1631.
33. Colombo, M. L. An update on vitamin E, tocopherol and tocotrienol-Perspectives. Molecules 2010, 15, 2103-2113.
34. Herrera, E.; Barbas, C. Vitamin E: Action, metabolism and perspectives. J. Physiol. Biochem. 2001, 57, 43-56.
35. Stocker, A. Molecular mechanisms of vitamin E transport. Ann. N. Y. Acad. Sci. 2004, 1031, 44-59.
36. Chin, K.-Y.; Ima-Nirwana, S. Vitamin E as an antiosteoporotic agent via receptor activator of nuclear factor κ-B ligand signaling disruption: Current evidence and other potential research areas. Evid. Based Complement. Alternat. Med. 2012, 2012, doi: 10. 1155/2012/747020.
37. Chin, K.-Y.; Mo, H.; Soelaiman, I.-N. A review of the possible mechanisms of action of tocotrienol-A potential antiosteoporotic agent. Curr. Drug Targets 2013, 14, 1533-1541.
38. Ahn, K. H.; Jung, H. K.; Jung, S. E.; Yi, K. W.; Tae, H.; Shin, J. H.; Kim, Y. T.; Hur, J. Y.; Kim, S. H.; Kim, T. Microarray analysis of gene expression during differentiation of human mesenchymal stem cells treated with vitamin E in vitro into osteoblasts. Korean J. Bone Metab. 2011, 18, 23-32.
39. Urban, K.; Hohling, H. J.; Luttenberg, B.; Szuwart, T.; Plate, U. An in vitro study of osteoblast vitality influenced by the vitamins C and E. Head Face Med. 2012, 8, doi: 10. 1186/1746-160X-8-25.
40. Soeta, S.; Higuchi, M.; Yoshimura, I.; Itoh, R.; Kimura, N.; Aamsaki, H. Effects of vitamin E on the osteoblast differentiation. J. Vet. Med. Sci. 2010, 72, 951-957.
41. Singh, U.; Devaraj, S.; Jialal, I. Vitamin E, oxidative stress, and inflammation. Annu. Rev. Nutr. 2005, 25, 151-174.
42. Singh, U. M. A.; Jialal, I. Anti-inflammatory effects of α-tocopherol. Ann. N. Y. Acad. Sci. 2004, 1031, 195-203.
43. Müller, L.; Theile, K.; Böhm, V. In vitro antioxidant activity of tocopherols and tocotrienols and comparison of vitamin E concentration and lipophilic antioxidant capacity in human plasma. Mol. Nutr. Food Res. 2010, 54, 731-742.
44. Feresin, R. G.; Johnson, S. A.; Elam, M. L.; Kim, J. S.; Khalil, D. A.; Lucas, E. A.; Smith, B. J.; Payton, M. E.; Akhter, M. P.; Arjmandi, B. H. Effects of vitamin E on bone biomechanical and histomorphometric parameters in ovariectomized rats. J. Osteoporos. 2013, 2013, doi: 10. 1155/2013/825985.
45. Muhammad, N.; Luke, D. A.; Shuid, A. N.; Mohamed, N.; Soelaiman, I. N. Two different isomers of vitamin E prevent bone loss in postmenopausal osteoporosis rat model. Evid. Based Complement. Alternat. Med. 2012, 2012, doi: 10. 1155/2012/161527.
46. Nazrun, A.; Khairunnur, A.; Norliza, M.; Norazlina, M.; Ima Nirwana, S. Effects of palm tocotrienol on oxidative stress and bone strength in ovariectomised rats. Med. Health 2008, 3, 83-90.
47. Norazlina, M.; Ima Nirwana, S.; Gapor, M. T.; Khalid, B. Palm vitamin E is comparable to α-tocotrienol in maintaining bone mineral density in ovariectomised female rats. Exp. Clin. Endocrinol. Diabetes 2000, 108, 1-6.
48. Hermizi, H.; Faizah, O.; Ima-Nirwana, S.; Ahmad Nazrun, S.; Norazlina, M. Beneficial effects of tocotrienol and tocopherol on bone histomorphometric parameters in sprague-dawley male rats after nicotine cessation. Calcif. Tissue Int. 2009, 84, 65-74.
49. Norazlina, M.; Hermizi, H.; Faizah, O.; Ima-Nirwana, S. Vitamin E reversed nicotine-induced toxic effects on bone biochemical markers in male rats. Arch. Med. Sci. 2010, 6, 505-512.
50. Ahmad, N. S.; Khalid, B. A. K.; Luke, D. A.; Ima Nirwana, S. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin. Exp. Pharmacol. Physiol. 2005, 32, 761-770.
51. Fujita, K.; Iwasaki, M.; Ochi, H.; Fukuda, T.; Ma, C.; Miyamoto, T.; Takitani, K.; Negishi-Koga, T.; Sunamura, S.; Kodama, T.; et al. Vitamin E decreases bone mass by stimulating osteoclast fusion. Nat. Med. 2012, 18, 589-594.
52. Iwaniec, U. T.; Turner, R. T.; Smith, B. J.; Stoecker, B. J.; Rust, A.; Zhang, B.; Vasu, V. T.; Gohil, K.; Cross, C. E.; Traber, M. G. Evaluation of long-term vitamin E insufficiency or excess on bone mass, density, and microarchitecture in rodents. Free Radic. Biol. Med. 2013, 65, 1209-1214.
53. Smith, B. J.; Lucas, E. A.; Turner, R. T.; Evans, G. L.; Lerner, M. R.; Brackett, D. J.; Stoecker, B. J.; Arjmandi, B. H. Vitamin E provides protection for bone in mature hindlimb unloaded male rats. Calcif. Tissue Int. 2005, 76, 272-279.
54. Arjmandi, B. H.; Juma, S.; Beharka, A.; Bapna, M. S.; Akhter, M.; Meydani, S. N. Vitamin E improves bone quality in the aged but not in young adult male mice. J. Nutr. Biochem. 2002, 13, 543-549.
55. Maggio, D.; Barabani, M.; Pierandrei, M.; Polidori, M. C.; Catani, M.; Mecocci, P.; Senin, U.; Pacifici, R.; Cherubini, A. Marked decrease in plasma antioxidants in aged osteoporotic women: Results of a cross-sectional study. J. Clin. Endocrinol. Metab. 2003, 88, 1523-1527.
56. Ostman, B.; Michaelsson, K.; Helmersson, J.; Byberg, L.; Gedeborg, R.; Melhus, H.; Basu, S. Oxidative stress and bone mineral density in elderly men: Antioxidant activity of α-tocopherol. Free Radic. Biol. Med. 2009, 47, 668-673.
57. Hamidi, M. S.; Corey, P. N.; Cheung, A. M. Effects of vitamin E on bone turnover markers among us postmenopausal women. J. Bone Miner. Res. 2012, 27, 1368-1380.
58. Melhus, H.; Michaelsson, K.; Holmberg, L.; Wolk, A.; Ljunghall, S. Smoking, antioxidant vitamins, and the risk of hip fracture. J. Bone Miner. Res. 1999, 14, 129-135.
59. Zhang, J.; Munger, R. G.; West, N. A.; Cutler, D. R.; Wengreen, H. J.; Corcoran, C. D. Antioxidant intake and risk of osteoporotic hip fracture in Utah: An effect modified by smoking status. Am. J. Epidemiol. 2006, 163, 9-17.
60. Chan, R.; Woo, J.; Lau, W.; Leung, J.; Xu, L.; Zhao, X.; Yu, W.; Lau, E.; Pocock, N. Effects of lifestyle and diet on bone health in young adult chinese women living in Hong Kong and Beijing. Food Nutr. Bull. 2009, 30, 370-378.
61. Michaëlsson, K.; Wolk, A.; Byberg, L.; Ärnlöv, J.; Melhus, H. Intake and serum concentrations of α-tocopherol in relation to fractures in elderly women and men: 2 Cohort studies. Am. J. Clin. Nutr. 2014, 99, 107-114.
62. Lodge, J. K.; Hall, W. L.; Jeanes, Y. M.; Proteggente, A. R. Physiological factors influencing vitamin E biokinetics. Ann. N. Y. Acad. Sci. 2004, 1031, 60-73.
63. Jeanes, Y. M.; Hall, W. L.; Ellard, S.; Lee, E.; Lodge, J. K. The absorption of vitamin E is influenced by the amount of fat in a meal and the food matrix. Br. J. Nutr. 2004, 92, 575-579.
64. Major, J. M.; Yu, K.; Wheeler, W.; Zhang, H.; Cornelis, M. C.; Wright, M. E.; Yeager, M.; Snyder, K.; Weinstein, S. J.; Mondul, A.; et al. Genome-wide association study identifies common variants associated with circulating vitamin E levels. Hum. Mol. Genet. 2011, 20, 3876-3883.
65. Traber, M. G. Vitamin E and K interactions-A 50-year-old problem. Nutr. Rev. 2008, 66, 624-629.
66. Cranenburg, E. C. M.; Schurgers, L. J.; Vermeer, C. Vitamin K: The coagulation vitamin that became omnipotent. Thrombosis Haemost. 2007, 98, 120-125.
67. Bügel, S. Vitamin K and Bone Health in Adult Humans. In Vitamins & Hormones; Gerald, L., Ed.; Academic Press: Waltham, MA, USA, 2008; Volume 78, pp. 393-416.
68. Takahashi, O.; Ichikawa, H.; Sasaki, M. Hemorrhagic toxicity of D-α-tocopherol in the rat. Toxicology 1990, 63, 157-165.
69. Wheldon, G.; Bhatt, A.; Keller, P.; Hummler, H. D, 1-α-tocopheryl acetate (vitamin E): A long term toxicity and carcinogenicity study in rats. Int. J. Vitam. Nutr. Res. 1983, 53, 287-296.
70. Frank, J.; Weiser, H.; Biesalski, H. Interaction of vitamins E and K: Effect of high dietary vitamin E on phylloquinone activity in chicks. Int. J. Vitam. Nutr. Res. 1997, 67, 242-247.
71. Booth, S. L.; Golly, I.; Sacheck, J. M.; Roubenoff, R.; Dallal, G. E.; Hamada, K.; Blumberg, J. B. Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. Am. J. Clin. Nutr. 2004, 80, 143-148.
72. Tsugawa, N.; Shiraki, M.; Suhara, Y.; Kamao, M.; Ozaki, R.; Tanaka, K.; Okano, T. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J. Bone Miner. Metab. 2008, 26, 79-85.
73. Kanai, T.; Takagi, T.; Masuhiro, K.; Nakamura, M.; Iwata, M.; Saji, F. Serum vitamin K level and bone mineral density in post-menopausal women. Int. J. Gynecol. Obstet. 1997, 56, 25-30.
74. Hosomi, A.; Arita, M.; Sato, Y.; Kiyose, C.; Ueda, T.; Igarashi, O.; Arai, H.; Inoue, K. Affinity for α-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 1997, 409, 105-108.
75. Ikeda, S.; Tohyama, T.; Yoshimura, H.; Hamamura, K.; Abe, K.; Yamashita, K. Dietary α-tocopherol decreases α-tocotrienol but not γ-tocotrienol concentration in rats. J. Nutr. 2003, 133, 428-434.
76. Ha, H.; Lee, J.-H.; Kim, H.-N.; Lee, Z. H. Α-tocotrienol inhibits osteoclastic bone resorption by suppressing RANKL expression and signaling and bone resorbing activity. Biochem. Biophys. Res. Commun. 2011, 406, 546-551.
77. Handelman, G. J.; Machlin, L. J.; Fitch, K.; Weiter, J. J.; Dratz, E. A. Oral α-tocopherol supplements decrease plasma γ-tocopherol levels in humans. J. Nutr. 1985, 115, 80-813.
78. Huang, H.-Y.; Appel, L. J. Supplementation of diets with α-tocopherol reduces serum concentrations of γ-and δ-tocopherol in humans. J. Nutr. 2003, 133, 3137-3140.
79. Kontush, A.; Finckh, B.; Karten, B.; Kohlschütter, A.; Beisiegel, U. Antioxidant and prooxidant activity of α-tocopherol in human plasma and low density lipoprotein. J. Lipid Res. 1996, 37, 1436-1448.